Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

Business Leaders

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors 
HomeAll NewsMost read newsBusiness Leaders Biography
Portrait de Karen Smith
Age : 52
Public asset : 1,771,783 USD
Country of residence : Unknown
Linked companies : Acceleron Pharma Inc. - Emergent BioSolutions Inc. - Sangamo Therapeutics, Inc. - Antares Pharma, Inc.

Biography of Karen Smith 
Dr. Karen L. Smith is a Chief Medical Officer at Emergent BioSolutions, Inc., an Independent Director at Antares Pharma, Inc., an Independent Director at Sangamo Therapeutics, Inc. and an Independent Director at Acceleron Pharma, Inc. She is on the Board of Directors at Antares Pharma, Inc., Sangamo Therapeutics, Inc. and Acceleron Pharma, Inc. Dr. Smith was previously employed as a President & Chief Executive Officer by Medeor Therapeutics, Inc., a Chief Executive Officer by Eliminate Cancer, Inc., a Director & Vice President by Celator Pharmaceuticals, Inc., a Non-Executive Director by Forward Pharma A/S, a Chief Medical Officer & EVP-Research & Development by Jazz Pharmaceuticals Plc, a SVP-Global Medical Affairs & Head-Dermatology by Allergan, Inc., a Head-External Medical Relations by AstraZeneca LP, a Head-US Clinical Operations by Bristol Myers Squibb Co., and a Chief Executive Officer by Boron Molecular Ltd. She also served on the board at Sucampo Pharmaceuticals, Inc. She received her undergraduate degree from Curtin University of Technology, a graduate degree from the University of Salford, an MBA from the University of New England (Australia), a doctorate degree from the University of Warwick and a doctorate degree from The University of Western Australia.


Current positions of Karen Smith 
Holdings of Karen Smith 
Karen Smith : Personal Network 
Most Read News 
09/04BERNARD ARNAULT : There is no conflict with Arnault
RE
09/07GEORGE SOROS : Soros says BlackRock's China investments likely to lose money - WSJ
RE
09/14BRAD SMITH : Microsoft to buy back up to $60 billion in shares; names Brad Smith vice chair
RE
09/09FRANCESCO GAETANO CALTAGIRONE : Italy's Caltagirone ups Generali stake to just over 6%
RE
09/14CATHIE WOOD : ARK Invest's Wood expects market rotation back to growth stocks
RE
09/09ELON MUSK : Tesla's Musk asks staff to 'go super hardcore' to ensure decent Q3 delivery number
RE
09/13MARTIN SORRELL : Sorrell's S4 Capital raises annual profit outlook for a third time
RE
09/08ELON MUSK : Amazon.com goes for jugular in FCC spat with SpaceX's Musk
RE
09/08BILL GATES : Bill Gates' investment firm to take control of Four Seasons in $2.21 billion deal
RE
09/17STELIOS HAJI-IOANNOU : EasyJet shareholder Stelios Haji-Ioannou shuns rights issue -source
RE
More news


© 2021 People and Ownership :   
Karen Smith : Connections 


Latest news about Karen Smith 
07/28Reservoir Media Management, Inc. completed the acquisition of Roth CH Acquisition II Co. from CR Financial Holdings, Inc., Polar Asset Management Partners Inc., Castle Creek Arbitrage, LLC, 683 Capital Management, LLC and others in a reverse merger transaction.
CI
07/23Microvast, Inc. completed the acquisition of Tuscan Holdings Corp. from Polar Asset Management Partners Inc., Weiss Asset Management LP, Stephen A. Vogel and others in a reverse merger transaction.
CI
05/24NeuroRx, Inc. completed the acquisition of Big Rock Partners Acquisition Corp. from BRAC Lending Group LLC, EarlyBirdCapital, Inc., Big Rock and others in a reverse merger transaction.
CI
05/07Science 37, Inc. entered into a definitive agreement to acquire LifeSci Acquisition II Corp. from LifeSci Holdings, LLC and others in a reverse merger transaction for $1.1 billion.
CI
04/20Kontoor Brands Appoints Karen Smith as Executive Vice President of Global Supply Chain
CI
04/16MyMD Pharmaceuticals, Inc. completed the acquisition of Akers Biosciences, Inc. in a reverse merger transaction.
CI
04/14Reservoir Media Management, Inc. entered into a definitive agreement to acquire Roth CH Acquisition II Co. for approximately $740 million in a reverse merger transaction.
CI
More news